Search details
1.
Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trial.
Antimicrob Agents Chemother
; 68(2): e0100423, 2024 Feb 07.
Article
in English
| MEDLINE | ID: mdl-38092664
2.
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
N Engl J Med
; 385(27): 2531-2543, 2021 12 30.
Article
in English
| MEDLINE | ID: mdl-34965338
3.
Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12â years and older: a PK substudy of the SMILE trial.
J Antimicrob Chemother
; 78(4): 1041-1049, 2023 04 03.
Article
in English
| MEDLINE | ID: mdl-36869720
4.
Current management of late onset neonatal bacterial sepsis in five European countries.
Eur J Pediatr
; 173(8): 997-1004, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24522326
5.
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial.
EClinicalMedicine
; 60: 102025, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37304494
6.
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children.
Clin Infect Dis
; 46(10): 1601-8, 2008 May 15.
Article
in English
| MEDLINE | ID: mdl-18419497
7.
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial.
PLoS One
; 13(4): e0196239, 2018.
Article
in English
| MEDLINE | ID: mdl-29684092
8.
Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy.
J Pediatric Infect Dis Soc
; 6(3): e109-e115, 2017 Sep 01.
Article
in English
| MEDLINE | ID: mdl-28903520
9.
Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults.
AIDS
; 20(7): 1039-49, 2006 Apr 24.
Article
in English
| MEDLINE | ID: mdl-16603857
10.
A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial.
Antivir Ther
; 11(7): 857-67, 2006.
Article
in English
| MEDLINE | ID: mdl-17302248
11.
Experience using MedDRA for global events coding in HIV clinical trials.
Contemp Clin Trials
; 27(1): 13-22, 2006 Feb.
Article
in English
| MEDLINE | ID: mdl-16288902
12.
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.
J Acquir Immune Defic Syndr
; 70(1): 42-53, 2015 Sep 01.
Article
in English
| MEDLINE | ID: mdl-26322666
13.
Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
Antivir Ther
; 7(2): 113-21, 2002 Jun.
Article
in English
| MEDLINE | ID: mdl-12212923
14.
Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bands.
Pediatr Infect Dis J
; 33(3): 301-5, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24356253
15.
Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions.
AIDS
; 27(4): 579-89, 2013 Feb 20.
Article
in English
| MEDLINE | ID: mdl-23135172
16.
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
Lancet Infect Dis
; 11(4): 273-83, 2011 Apr.
Article
in English
| MEDLINE | ID: mdl-21288774
17.
HIV-1 drug resistance and second-line treatment in children randomized to switch at low versus higher RNA thresholds
J. acquir immune defic. syndr
; 70(1): 42-53, Sept. 2015. ilus, tab
Article
in English
| SES-SP, SES SP - Instituto de Infectologia Emílio Ribas, SES-SP | ID: biblio-1016849
18.
External validation of atazanavir/ritonavir genotypic score in HIV-1 protease inhibitor-experienced patients.
J Acquir Immune Defic Syndr
; 42(1): 127-8, 2006 May.
Article
in English
| MEDLINE | ID: mdl-16639354
Results
1 -
18
de 18
1
Next >
>>